Document is current
Any future updates will be listed below
-
Authors
Sridhar, Saranya https://orcid.org/0000-0002-4267-3102
Chicz, Roman M.
Warren, William
Tartaglia, Jim
Savarino, Stephen
Gurunathan, Sanjay
Toussaint, Jean-Francois
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | Biomedical Advanced Research and Development Authority (HHSO100201600005I)
- License Information
-
More Information
Article History
Received: 14 June 2022
Accepted: 22 September 2022
First Online: 2 October 2022
Competing interests
: All authors are employees of Sanofi and hold stock options. Sanofi is developing a recombinant Beta strain vaccine booster in collaboration with GSK (AS03 adjuvant) and funded in part by Sanofi and the US Government through the Biomedical Advanced Research and Development Authority (BARDA) under contract HHSO100201600005I.
